
Advances in Glaucoma Optic Atrophy Treatment in Canada with Stem Cell Therapy
Glaucoma is a type of eye disease. It negatively affects the nerve. This results in a condition referred to as optic atrophy. This damage can lead to blinding complications if not treated. While traditional approaches to managing glaucoma is to control intraocular pressure in an effort to arrest progression of the disease, they fail to address the issue of reversing optic nerve deterioration. Optic atrophy treatment with stem cell therapy is presented as a new solution.
Glaucoma Optic Atrophy
Glaucoma is due to raised intraocular pressure. It puts pressure on the optic nerve. This reduces the peripheral vision. Then ultimately the central vision as well. Migration of poorly treated glaucoma is associated with optic atrophy. This is the state of optic nerve damage. It can even be the thinning of the nerve due to ineffective functioning of nerve fibers. Conventional therapies include eye drops, pills, and lasers, or surgery that seeks to reduce eye pressure in an effort to stall further harm. However, optic nerve fibers cannot reorganise once they are damaged, which is why seeing loss consequent to optic atrophy is irreversible.
How stem cell therapy operates in the treatment of optic atrophy
They are able to produce neural or retinal cells which can replace dead optic nerve fibres or build new function. Autologous stem cell therapy for glaucoma optic atrophy entails the administration of stem cells either directly into the eye or to the aetiological region. These cells then help restore or replace damaged nerve tissue and also help reduce inflammation which may conserve and enhance vision.
Advantages of stem cell therapy for glaucoma optic atrophy
Stem cell therapy offers several key advantages over traditional treatments for glaucoma optic atrophy in Canada:
Stem Cell Therapy at Eyestemcellcenter
At Eye Stem Cell Center in Canada, we try to provide the best services to the patient and continue to extend research and development on eye diseases such as glaucoma optic atrophy. We offer all patients individualized treatment programs. We selectively employ technology, to offer stem cell therapy without invasive damage but with highly positive prognosis.

